LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 128 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.94 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $461,000 | -16.3% | 82,915 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $551,000 | -68.9% | 82,915 | -50.0% | 0.00% | 0.0% |
Q3 2018 | $1,770,000 | +76.3% | 165,830 | +98.2% | 0.00% | 0.0% |
Q2 2018 | $1,004,000 | +51.7% | 83,674 | +8.4% | 0.00% | 0.0% |
Q1 2018 | $662,000 | -13.2% | 77,189 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $763,000 | -19.6% | 77,189 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $949,000 | -25.3% | 77,189 | 0.0% | 0.00% | -50.0% |
Q2 2017 | $1,270,000 | +24.5% | 77,189 | +8.5% | 0.00% | +100.0% |
Q1 2017 | $1,020,000 | -31.0% | 71,112 | -33.5% | 0.00% | -50.0% |
Q4 2016 | $1,478,000 | +2.9% | 106,890 | +34.4% | 0.00% | 0.0% |
Q3 2016 | $1,437,000 | +47.7% | 79,512 | +17.3% | 0.00% | 0.0% |
Q2 2016 | $973,000 | +35.7% | 67,782 | +12.9% | 0.00% | +100.0% |
Q1 2016 | $717,000 | -10.3% | 60,041 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $799,000 | +23.9% | 60,041 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $645,000 | +33.5% | 60,041 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $483,000 | – | 60,041 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |